- Advertisement -

Functional Limitations In Biotechnology Risk Invalidity For Lack Of Enablement – JD Supra

On February 11, 2021, the Federal Circuit issued an opinion that suggests that inventions in fields where outcomes are unpredictable, such as biotechnology and...

LabVantage named Global LIMS Company of the year by Frost & Sullivan

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS platforms enabling rapid deployment at reduced costs, today announced it has...

Medovex’s Transition to H-CYTE Underscores Biotechnology Focus – GlobeNewswire

ALPHARETTA, Ga., June 24, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: Symbol MDVX) ("Medovex" or the "Company"), is transitioning to its new name H-CYTE...

Female body odor variations can shape male behavior and emotions

Researchers at the University of Tokyo explored how female body odor can influence behaviors in men. They found certain scent compounds in female body...

Functional Phosphoproteomics Finds Resolutions with Ion Mobility

Broadcast Date: March 14, 2023Time: 8:00 am PT, 11:00 am ET, 17:00 CET REGISTER NOW Phosphoproteomics is a cutting-edge research area that aims to understand...

Beyond Antibodies: Unlocking New Targets and Applications with Optimer

View eBook Across biomedical research and drug development, the boundaries of possibility are shifting. Scientists are uncovering new disease mechanisms, redefining diagnostic strategies, and designing...

Parabilis Files for IPO, a Day After Signing Up-to-$2.3B Regeneron Collaboration

Parabilis Medicines, the developer of drugs and antibody-drug conjugates targeting historically undruggable protein targets and based on stabilized helical peptides or Helicons, has filed...

AI-created miniproteins show promise for targeting hard-to-treat diseases

G protein-coupled receptors, or GPCRs, sit in the plasma membrane, the boundary that defines the inside and outside of a living cell. They communicate...

Parabilis Files for IPO, a Day After Signing Up-to-$2.3B Regeneron Collaboration

Parabilis Medicines, the developer of drugs and antibody-drug conjugates targeting historically undruggable protein targets and based on stabilized helical peptides or Helicons, has filed...

AI-created miniproteins show promise for targeting hard-to-treat diseases

G protein-coupled receptors, or GPCRs, sit in the plasma membrane, the boundary that defines the inside and outside of a living cell. They communicate...

Bioluminescent fungi reveal pathways for advanced biotechnology and medical applications

Like fireflies and many deep-sea creatures, certain fungi can naturally emit light through bioluminescence pathways in which specialized enzymes convert chemical energy into visible...

more new items

Parabilis Files for IPO, a Day After Signing Up-to-$2.3B Regeneron Collaboration

Parabilis Medicines, the developer of drugs and antibody-drug conjugates targeting historically undruggable protein targets and based on stabilized helical peptides or Helicons, has filed...

AI-created miniproteins show promise for targeting hard-to-treat diseases

G protein-coupled receptors, or GPCRs, sit in the plasma membrane, the boundary that defines the inside and outside of a living cell. They communicate...

Bioluminescent fungi reveal pathways for advanced biotechnology and medical applications

Like fireflies and many deep-sea creatures, certain fungi can naturally emit light through bioluminescence pathways in which specialized enzymes convert chemical energy into visible...